The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This single-blinded, randomized-controlled trial compares the efficacy of ultrasound-guided
onabotulinumtoxinA (BTX-A) injections to the flexor digitorum brevis with current standard of
care corticosteroid injections to the plantar fascia for the treatment of refractory plantar
fasciitis in patients that have failed six weeks of non-operative treatment.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Western Institute for Veterans Research
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A Cortisone Dexamethasone